Clinical Trial Update: TACE vs TACE+SBRT for Unresectable Hepatocellular Cancer [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/Phase 3 trial comparing transarterial chemoembolization (TACE) alone versus TACE combined with stereotactic body radiotherapy (SBRT) for unresectable he…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• SBRT (stereotactic body radiotherapy)
• TACE

Snippet

Sponsor: Tata Memorial Hospital | Conditions: Carcinoma, Hepatocellular | Phase 2, Phase 3 | Status: UNKNOWN